Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments is a research paper published in Journal for ImmunoTherapy of Cancer (2021). On theSindex it has a DataRank of 1.3. It has been cited 45 times, with 37 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.574
From this paper's citation signal
Citation Network Contribution
0.717
From 34 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 37 citers.
Empire State Development Corporation
Grant: Accelerator Grant
Empire State Development Corporation
Grant: University at Buffalo CAT
National Institutes of Health
Grant: CA034196
National Institutes of Health
Grant: HL-70227
National Institutes of Health
Grant: R01 CA204261
National Institutes of Health
Grant: R21 CA205794
National Institutes of Health
Grant: R43 CA224602
National Institutes of Health
Grant: R43 CA257721-01A1
National Institutes of Health
Grant: R50CA2111108
NCI NIH HHS
Grant: R50 CA211108
NCI NIH HHS
Grant: P30 CA016056
NCI NIH HHS
Grant: P30 CA034196
NHLBI NIH HHS
Grant: R01 HL070227
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R43 CA257721
National Institutes of Health
Grant: 3P30CA034196-26S1
Cancer Center Support (CORE) Grant
National Institutes of Health
Grant: 5P30CA016056-40
Roswell Park Cancer Institute Cancer Center Support Grant
National Institutes of Health
Grant: 1R43CA257721-01A1
Novel Drug for Cancer Immunotherapy that Targets Phosphatidylserine
National Institutes of Health
Grant: 5R21CA205794-04
PD-1 Blockade and Neoantigen-Specific T Cell Immunity
National Institutes of Health
Grant: 1R43CA224602-01A1
Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy
National Institutes of Health
Grant: 5R29CA070227-05
STATISTICAL METHODS FOR PROSTATE CANCER RESEARCH
National Institutes of Health
Grant: 1R01CA204261-01A1
Integrated Discovery Pipeline for Tumor Neoantigens
FWCI
2.14
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals